Literature DB >> 33137440

Incidence of dermatologic adverse events in patients with cancer treated with concurrent immune checkpoint inhibitors and radiation therapy: A systematic review and meta-analysis.

Bernice Y Yan1, Gloria Wasilewski2, Mario E Lacouture3, Christopher A Barker4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33137440      PMCID： PMC7897249          DOI： 10.1016/j.jaad.2020.10.071

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

1.  Impact of dermatologic adverse events on quality of life in 283 cancer patients: a questionnaire study in a dermatology referral clinic.

Authors:  Alyx C Rosen; Emily C Case; Stephen W Dusza; Yevgeniy Balagula; Jennifer Gordon; Dennis P West; Mario E Lacouture
Journal:  Am J Clin Dermatol       Date:  2013-08       Impact factor: 7.403

Review 2.  The risk of rash associated with ipilimumab in patients with cancer: a systematic review of the literature and meta-analysis.

Authors:  Kira Minkis; Benjamin C Garden; Shenhong Wu; Melissa P Pulitzer; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2013-01-26       Impact factor: 11.527

Review 3.  Pruritus in patients treated with targeted cancer therapies: systematic review and meta-analysis.

Authors:  Courtney J Ensslin; Alyx C Rosen; Shenhong Wu; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2013-08-24       Impact factor: 11.527

Review 4.  Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor.

Authors:  V R Belum; B Benhuri; M A Postow; M D Hellmann; A M Lesokhin; N H Segal; R J Motzer; S Wu; K J Busam; J D Wolchok; M E Lacouture
Journal:  Eur J Cancer       Date:  2016-04-01       Impact factor: 9.162

Review 5.  Immune checkpoint inhibitor-related dermatologic adverse events.

Authors:  Amaris N Geisler; Gregory S Phillips; Dulce M Barrios; Jennifer Wu; Donald Y M Leung; Andrea P Moy; Jeffrey A Kern; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2020-05-23       Impact factor: 11.527
  5 in total
  1 in total

1.  Risk of Adverse Events in Cancer Patients Receiving Nivolumab With Ipilimumab: A Meta-Analysis.

Authors:  Xin Zhao; Fengwei Gao; Jie Yang; Hua Fan; Qingyun Xie; Kangyi Jiang; Jie Gong; Benjian Gao; Qian Yang; Zehua Lei
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.